Literature DB >> 21353137

Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.

Arnt F A Schellekens1, Sasja F Mulder, Philip F P van Eijndhoven, Tineke J Smilde, Carla M L van Herpen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21353137     DOI： 10.1016/j.genhosppsych.2010.09.008

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN： 0163-8343            Impact factor:   3.238


× No keyword cloud information.
  2 in total

1.  Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.

Authors:  Paulo L Lizano; Matcheri S Keshavan; Neeraj Tandon; Ian T Mathew; Suraj Sarvode Mothi; Debra M Montrose; Jeffrey K Yao
Journal:  Schizophr Res       Date:  2015-12-11       Impact factor: 4.939

2.  Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study.

Authors:  Sasja F Mulder; Dirk Bertens; Ingrid M E Desar; Kris C P Vissers; Peter F A Mulders; Cornelis J A Punt; Dick-Johan van Spronsen; Johan F Langenhuijsen; Roy P C Kessels; Carla M L van Herpen
Journal:  BMC Cancer       Date:  2014-03-24       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.